MX2018013438A - Pharmaceutical compositions for the effective treatment of colorectal cancer. - Google Patents

Pharmaceutical compositions for the effective treatment of colorectal cancer.

Info

Publication number
MX2018013438A
MX2018013438A MX2018013438A MX2018013438A MX2018013438A MX 2018013438 A MX2018013438 A MX 2018013438A MX 2018013438 A MX2018013438 A MX 2018013438A MX 2018013438 A MX2018013438 A MX 2018013438A MX 2018013438 A MX2018013438 A MX 2018013438A
Authority
MX
Mexico
Prior art keywords
colorectal cancer
pharmaceutical compositions
effective treatment
kras4b
compound
Prior art date
Application number
MX2018013438A
Other languages
Spanish (es)
Inventor
NOVA Predro CRUZ
Díaz Paola Briseño
Mejia Miguel Ángel Vargas
Original Assignee
Centro De Investig Y De Estudios Avanzados Del I P N
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centro De Investig Y De Estudios Avanzados Del I P N filed Critical Centro De Investig Y De Estudios Avanzados Del I P N
Priority to MX2018013438A priority Critical patent/MX2018013438A/en
Priority to PCT/IB2019/059380 priority patent/WO2020089842A1/en
Publication of MX2018013438A publication Critical patent/MX2018013438A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

The present invention describes pharmaceutical compositions comprising a compound that has the formula (Compound C19), which specifically inhibits mutated GTPase KRAS4b, making the compositions useful for the effective treatment of colorectal cancer. Compound C19 acts as a stabilizer of the KRAS4b-PDE? complex, decreasing the proliferation of cancer cells in colorectal cancer, and increasing apoptosis through decreased activation of KRAS4b oncogenic signaling.
MX2018013438A 2018-11-01 2018-11-01 Pharmaceutical compositions for the effective treatment of colorectal cancer. MX2018013438A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MX2018013438A MX2018013438A (en) 2018-11-01 2018-11-01 Pharmaceutical compositions for the effective treatment of colorectal cancer.
PCT/IB2019/059380 WO2020089842A1 (en) 2018-11-01 2019-11-01 Pharmaceutical compositions for the effective treatment of colorectal cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2018013438A MX2018013438A (en) 2018-11-01 2018-11-01 Pharmaceutical compositions for the effective treatment of colorectal cancer.

Publications (1)

Publication Number Publication Date
MX2018013438A true MX2018013438A (en) 2022-07-20

Family

ID=70463876

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018013438A MX2018013438A (en) 2018-11-01 2018-11-01 Pharmaceutical compositions for the effective treatment of colorectal cancer.

Country Status (2)

Country Link
MX (1) MX2018013438A (en)
WO (1) WO2020089842A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015054572A1 (en) * 2013-10-10 2015-04-16 Araxes Pharma Llc Inhibitors of kras g12c

Also Published As

Publication number Publication date
WO2020089842A1 (en) 2020-05-07

Similar Documents

Publication Publication Date Title
MX2023005804A (en) Pyridazinones as parp7 inhibitors.
GEP20217281B (en) 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer
PH12020500033A1 (en) Macrocyclic compounds and uses thereof
EA201990187A1 (en) PYRIMIDINE ANTIPROLIFERATION AGENTS
ZA201906832B (en) Novel psma-binding agents and uses thereof
PH12018502535A1 (en) Substituted carbonucleoside derivatives useful as anticancer agents
GEP20186933B (en) Substituted dihydroisoquinoline compounds
MX2020006365A (en) Quinazolinones as parp14 inhibitors.
MX2022001310A (en) Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl compounds.
MX2020009413A (en) Car-cd30 t cells for treatment of cd30+ tumors.
TN2019000211A1 (en) Antitumoral compounds
MX2019010149A (en) Inhibition of smarca2 for treatment of cancer.
MX2018006953A (en) Monomaleimide-functionalized platinum compounds for cancer therapy.
EP4306173A3 (en) Compositions and methods for treating cancers
WO2019023315A3 (en) Rac inhibitors
MX2019002430A (en) Anti-tumor agent, anti-tumor effect enhancer, and anti-tumor kit.
PH12017500910A1 (en) Use of sigma receptor ligands in osteoarthritis
MX2021008225A (en) Compositions and methods for treatment of abnormal cell growth.
EA201691896A1 (en) CONNECTIONS AND METHODS OF THEIR APPLICATION
MX2018013438A (en) Pharmaceutical compositions for the effective treatment of colorectal cancer.
WO2018146390A8 (en) Use of a compound of the diuretics class for treating cancer
MX2018001575A (en) Tricyclic compounds and their use in the treatment of cancer.
MX2021011699A (en) Quinoline derivatives and their use for the treatment of cancer.
MX2018002612A (en) Pharmaceutical composition for tumor having isocitrate dehydrogenase mutation, antitumor agent and use thereof.
MX2017014463A (en) Cabazitaxel and its use for treating cancer.